Skip to main content
An official website of the United States government
Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Program Official
Principal Investigator
Guilherme Cantuaria
Awardee Organization

Northside Hospital Atlanta
United States

Fiscal Year
2025
Activity Code
UG1
Early Stage Investigator Grants (ESI)
Not Applicable
Project End Date

Georgia NCI Community Oncology Research Program (GA NCORP)

The Georgia Community Oncology Research Program (Community Site) represents the collaboration between two NCCCP community hospital-based cancer programs, Northside Hospital Cancer Institute in Atlanta, GA, and the Lewis Cancer & Research Pavilion in Savannah, GA, with investigators from a statewide research network of community hospital based and private practice oncologists through the Georgia Center for Oncology Research and Education (Georgia CORE). The proposed Community Site consortium provides care to approximately 23,000 newly diagnosed patients with cancer in Georgia and has enrolled over 3,300 patients to NCI-sponsored trials since 2014. Through an integrated organizational and leadership structure, leading cancer researchers in the components and partner research sites are poised to build on a 30-year history of collaboration to further enhance the quality of cancer care through improved access and enrollment to NCI-sponsored trials to address the goals of the NCORP. Four specific aims are implemented to achieve the overall goal of GA NCORP: 1) to increase the number of eligible patients at risk for, or diagnosed with, cancer and who are provided access to, and enroll in, cancer clinical trials within their community; 2) to enroll participants from all populations across all study types and settings to reduce cancer; 3) to create a balanced trial portfolio between treatment trials and cancer control and prevention trials; and 4) to increase accrual and expand network-wide participation in cancer care delivery research. Achieving these aims will improve the quality of care in Georgia through increasing cancer research in local communities, identifying best practices for research accruals, and maximizing capacity and expertise for cancer research statewide.

Publications

  • Cathcart-Rake E, Novotny P, Leon-Ferre R, Le-Rademacher J, Storrick EM, Adjei AA, Terstriep S, Glaser R, Giuliano A, Mitchell WR, Page S, Austin C, Deming RL, Ferreira MA, Lafky JM, Birrell SN, Loprinzi CL. A randomized, double-blind, placebo-controlled trial of testosterone for treatment of postmenopausal women with aromatase inhibitor-induced arthralgias: Alliance study A221102. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2021 Jan;29(1):387-396. Epub 2020 May 6. PMID: 32372176
  • Schneider BP, Zhao F, Ballinger TJ, Garcia SF, Shen F, Virani S, Cella D, Bales C, Jiang G, Hayes L, Miller N, Srinivasiah J, Stringer-Reasor EM, Chitalia A, Davis AA, Makower DF, Incorvati J, Simon MA, Mitchell EP, DeMichele A, Miller KD, Sparano JA, Wagner LI, Wolff AC. ECOG-ACRIN EAZ171: Prospective Validation Trial of Germline Predictors of Taxane-Induced Peripheral Neuropathy in Black Women With Early-Stage Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2024 Aug 20;42(24):2899-2907. Epub 2024 Jun 3. PMID: 38828938